- Home
- » Tags
- » Esmirtazapine
Top View
- Antidepressants for Insomnia in Adults (Review)
- Type of Article
- Pharmaceutical Appendix to the Tariff Schedule 2
- Customs Tariff - Schedule Xxi - 1
- (12) United States Patent (10) Patent N0.: US 8,729,070 B2 Glozman (45) Date of Patent: May 20, 2014
- The Carlat Psychiatry Report Medication Fact Book For
- Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) - Full Text View - Clinicaltrials.Gov
- Chiral Separation of Mirtazapine with a Lux® I-Amylose-3 Chiral Stationary Phase by HPLC Under General Normal Phase Mobile Phase Conditions
- Pharmaceutical Appendix to the Tariff Schedule 2
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- DRUG USE, IMPAIRED DRIVING and TRAFFIC ACCIDENTS Second Edition
- Managing Insomnia
- (12) Patent Application Publication (10) Pub. No.: US 2011/0054038A1 Glozman (43) Pub
- WHO Drug Information Vol. 20, No. 1, 2006
- Antidepressants for Insomnia in Adults (Review)
- Pharmacogenomics for Primary Care: an Overview
- (12) United States Patent (10) Patent No.: US 8,729,070 B2 Glozman (45) Date of Patent: May 20, 2014
- Dose Amitriptyline and Mirtazapine for Insomnia Disorder
- Schering-Plough Corporation 2000 Galloping Hill Road Kenilworth, NJ, 07033-0530
- Hans-Peter Landolt Derk-Jan Dijk Editors Sleep-Wake Neurobiology and Pharmacology Handbook of Experimental Pharmacology
- Clinical Psychopharmacology for Neurologists